Africa’s Researchers Playing Crucial Role in Advancing HIV Prevention #HIVR4P2024
[ad_1] Lima, Peru — Africa is contributing to groundbreaking data from the PURPOSE 2 study, which explores twice-yearly lenacapavir for HIV prevention. This study, with participants from South Africa and Uganda , is one of the scientific highlights showcased at the 5th HIV Research for Prevention Conference, better known as HIVR4P 2024, in Lima, Peru. A key development is the promising results from the PURPOSE 1 study, which demonstrated that lenacapavir, a biannual HIV prevention injectable, reduced HIV acquisitions by […]